Sale!

PRICKLE1 Gene Progressive Myoclonus Epilepsy Type 1A Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The PRICKLE1 Gene Progressive Myoclonus Epilepsy Type 1A Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the PRICKLE1 gene, which are associated with Progressive Myoclonus Epilepsy Type 1A (PME 1A). PME 1A is a rare genetic disorder characterized by myoclonic seizures, epileptic episodes, and potentially progressive neurological decline. The test is crucial for individuals displaying symptoms suggestive of PME 1A or for those with a family history of the condition, as it aids in confirming the diagnosis, understanding the disease’s progression, and tailoring appropriate treatment plans.

The testing process involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any genetic abnormalities in the PRICKLE1 gene. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in this specific gene. Early and precise diagnosis through the PRICKLE1 Gene Progressive Myoclonus Epilepsy Type 1A Genetic Test enables healthcare providers to offer better management strategies for affected individuals, potentially improving their quality of life.

Description

PRICKLE1 Gene Progressive Myoclonus Epilepsy Type 1A Genetic Test

Test Name: PRICKLE1 Gene Progressive Myoclonus Epilepsy Type 1A Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for PRICKLE1 Gene Progressive Myoclonus Epilepsy Type 1A NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PRICKLE1 Gene Progressive Myoclonus Epilepsy Type 1A.

Test Details: The PRICKLE1 gene is associated with a rare genetic disorder called Progressive Myoclonus Epilepsy Type 1A (PME1A). PME1A is characterized by progressive muscle twitches (myoclonus) and seizures (epilepsy) that typically begin in childhood or adolescence. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of an individual’s genes. In the case of PME1A, NGS can be used to identify any mutations or changes in the PRICKLE1 gene that may be causing the disorder. By performing an NGS genetic test for PME1A, healthcare professionals can determine if there are any genetic variants in the PRICKLE1 gene that may be responsible for the individual’s symptoms. This information can be useful for diagnosis, genetic counseling, and potentially guiding treatment options for affected individuals and their families. It is important to note that genetic testing for PME1A should be performed by a qualified healthcare professional or genetic counselor who can provide appropriate guidance and interpretation of the results.

Test Name	PRICKLE1 Gene Progressive myoclonus epilepsy type 1A Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Neurological Disorders
Doctor	Neurologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for PRICKLE1 Gene Progressive myoclonus epilepsy type 1A NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with PRICKLE1 Gene Progressive myoclonus epilepsy type 1A
Test Details	The PRICKLE1 gene is associated with a rare genetic disorder called Progressive Myoclonus Epilepsy Type 1A (PME1A). PME1A is characterized by progressive muscle twitches (myoclonus) and seizures (epilepsy) that typically begin in childhood or adolescence. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of an individual’s genes. In the case of PME1A, NGS can be used to identify any mutations or changes in the PRICKLE1 gene that may be causing the disorder. By performing an NGS genetic test for PME1A, healthcare professionals can determine if there are any genetic variants in the PRICKLE1 gene that may be responsible for the individual’s symptoms. This information can be useful for diagnosis, genetic counseling, and potentially guiding treatment options for affected individuals and their families. It is important to note that genetic testing for PME1A should be performed by a qualified healthcare professional or genetic counselor who can provide appropriate guidance and interpretation of the results.